Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xican Yu
TopBP1 Contributes to the Chemoresistance in Non-Small Cell Lung Cancer Through Upregulation of P53
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
P53 and Angiogenesis in Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer
Frontiers in Pharmacology
Pharmacology
LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
ALKBH3, a Human AlkB Homologue, Contributes to Cell Survival in Human Non-Small-Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Upregulation of Acetylcholinesterase Mediated by P53 Contributes to Cisplatin-Induced Apoptosis in Human Breast Cancer Cell
Journal of Cancer
Oncology
Antagonism Between HtrA3 and TGF-β1 Contributes to Metastasis in Non-Small-Cell Lung Cancer
Cancer Research
Cancer Research
Oncology
Small Cell Lung Cancer: Model of Circulating Tumor Cell Tumorospheres in Chemoresistance
Scientific Reports
Multidisciplinary
Lobaplatin-Induced Apoptosis Requires P53-Mediated P38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Roles of ERα and ERβ in Estrogen-Induced DDP Chemoresistance in Non-Small Cell Lung Cancer
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology